Duac: Difference between revisions
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
{{SIB}} | {{SIB}} | ||
[[Category: Drugs]] | [[Category: Drugs]] | ||
[[Category: Dermatology]] | |||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} |
Revision as of 15:01, 6 May 2009
WikiDoc Resources for Duac |
Articles |
---|
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Duac at Clinical Trials.gov Clinical Trials on Duac at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Duac
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Directions to Hospitals Treating Duac Risk calculators and risk factors for Duac
|
Healthcare Provider Resources |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
DUAC is the drug name for a topical cream that contains 1.28% Clindamycin Phosphate and 6.67% Benzoyl peroxide. The topical cream is effective in the treatment of acne. DUAC is a prescription drug that currently (Feb. 2006) does not have a generic version available making it expensive to purchase.